RVPH

0.30005.63%
LD

Les D. Funtleyder

Independent Director

Mr. Les D. Funtleyder is Analyst of Miller Tabak + Co., LLC. He is Portfolio Manager of Miller Tabak Advisors, LLC. He focuses on Healthcare. He is Portfolio Manager of MT Asset Management, LLC. He is Independent Director of Reviva Pharmaceuticals Holdings, Inc. from December 08, 2020. He joined the Reviva Pharmaceuticals Holdings, Inc. on December 08, 2020. He is Venture Partner of Zentynel Frontier Investments. He was Executive Officer of UBS Investment Bank, Research Division. He was Healthcare Strategist of Miller Tabak + Co., LLC, Research Division. He was Analyst of Bigelow & Co., Research Division. He was Interim Chief Executive Officer, CFO & Director of Applied Therapeutics, Inc. He was Interm CEO, CFO, Principal Financial Officer & Director of Applied Therapeutics, Inc. from December 20, 2024 to February 3 , 2026. He was CFO, Principal Financial Officer & Independent Director of Applied Therapeutics, Inc. from November 20, 2023. He was Independent Director of Applied Therapeutics, Inc. from April 27, 2019 to November 20, 2023. He was Interim CFO & Director of Applied Therapeutics, Inc. until April 27, 2019. He was employed at Applied Therapeutics, Inc. until February 3 , 2026. He has M.P.H from Mailman School of Public Health, Columbia University, B.A. in Economics & English from Tulane University.

Positions